List of HCPCS codes for: Temporary Codes (Q-codes) - Group Q0

HCPCS Code	Short Description	Long Description
Q0	Invest clinical research	Investigational clinical service provided in a clinical research study that is in an approved clinical research study
Q0035	Cardiokymography	Cardiokymography
Q0081	Infusion ther other than che	Infusion therapy, using other than chemotherapeutic drugs, per visit
Q0083	Chemo by other than infusion	Chemotherapy administration by other than infusion technique only (e.g., subcutaneous, intramuscular, push), per visit
Q0084	Chemotherapy by infusion	Chemotherapy administration by infusion technique only, per visit
Q0085	Chemo by both infusion and o	Chemotherapy administration by both infusion technique and other technique(s) (e.g., subcutaneous, intramuscular, push), per visit
Q0091	Obtaining screen pap smear	Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory
Q0092	Set up port xray equipment	Set-up portable x-ray equipment
Q0111	Wet mounts/ w preparations	Wet mounts, including preparations of vaginal, cervical or skin specimens
Q0112	Potassium hydroxide preps	All potassium hydroxide (koh) preparations
Q0113	Pinworm examinations	Pinworm examinations
Q0114	Fern test	Fern test
Q0115	Post-coital mucous exam	Post-coital direct, qualitative examinations of vaginal or cervical mucous
Q0138	Ferumoxytol, non-esrd	Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)
Q0139	Ferumoxytol, esrd use	Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (for esrd on dialysis)
Q0144	Azithromycin dihydrate, oral	Azithromycin dihydrate, oral, capsules/powder, 1 gram
Q0161	Chlorpromazine hcl 5mg oral	Chlorpromazine hydrochloride, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
Q0162	Ondansetron oral	Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
Q0163	Diphenhydramine hcl 50mg	Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen
Q0164	Prochlorperazine maleate 5mg	Prochlorperazine maleate, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
Q0166	Granisetron hcl 1 mg oral	Granisetron hydrochloride, 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 24 hour dosage regimen
Q0167	Dronabinol 2.5mg oral	Dronabinol, 2.5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
Q0169	Promethazine hcl 12.5mg oral	Promethazine hydrochloride, 12.5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
Q0173	Trimethobenzamide hcl 250mg	Trimethobenzamide hydrochloride, 250 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
Q0174	Thiethylperazine maleate10mg	Thiethylperazine maleate, 10 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
Q0175	Perphenazine 4mg oral	Perphenazine, 4 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
Q0177	Hydroxyzine pamoate 25mg	Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
Q0180	Dolasetron mesylate oral	Dolasetron mesylate, 100 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 24 hour dosage regimen
Q0181	Unspecified oral anti-emetic	Unspecified oral dosage form, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for a iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
Q0220	Tixagev and cilgav, 300mg	Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), 300 mg
Q0221	Tixagev and cilgav, 600mg	Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), 600 mg
Q0222	Bebtelovimab 175 mg	Injection, bebtelovimab, 175 mg
Q0224	Inj, pemivibart, 4500 mg	Injection, pemivibart, for the pre-exposure prophylaxis only, for certain adults and adolescents (12 years of age and older weighing at least 40 kg) with no known sars-cov-2 exposure, and who either have moderate-to-severe immune compromise due to a medical condition or receipt of immunosuppressive medications or treatments, and are unlikely to mount an adequate immune response to covid-19 vaccination, 4500 mg
Q0239	Bamlanivimab-xxxx	Injection, bamlanivimab-xxxx, 700 mg
Q0240	Casirivi and imdevi 600 mg	Injection, casirivimab and imdevimab, 600 mg
Q0243	Casirivimab and imdevimab	Injection, casirivimab and imdevimab, 2400 mg
Q0244	Casirivi and imdevi 1200 mg	Injection, casirivimab and imdevimab, 1200 mg
Q0245	Bamlanivimab and etesevima	Injection, bamlanivimab and etesevimab, 2100 mg
Q0247	Sotrovimab	Injection, sotrovimab, 500 mg
Q0249	Tocilizumab for covid-19	Injection, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, 1 mg
Q0477	Pwr module pt cable lvad rpl	Power module patient cable for use with electric or electric/pneumatic ventricular assist device, replacement only
Q0478	Power adapter, combo vad	Power adapter for use with electric or electric/pneumatic ventricular assist device, vehicle type
Q0479	Power module combo vad, rep	Power module for use with electric or electric/pneumatic ventricular assist device, replacement only
Q0480	Driver pneumatic vad, rep	Driver for use with pneumatic ventricular assist device, replacement only
Q0481	Microprcsr cu elec vad, rep	Microprocessor control unit for use with electric ventricular assist device, replacement only
Q0482	Microprcsr cu combo vad, rep	Microprocessor control unit for use with electric/pneumatic combination ventricular assist device, replacement only
Q0483	Monitor elec vad, rep	Monitor/display module for use with electric ventricular assist device, replacement only
Q0484	Monitor elec or comb vad rep	Monitor/display module for use with electric or electric/pneumatic ventricular assist device, replacement only
Q0485	Monitor cable elec vad, rep	Monitor control cable for use with electric ventricular assist device, replacement only
Q0486	Mon cable elec/pneum vad rep	Monitor control cable for use with electric/pneumatic ventricular assist device, replacement only
Q0487	Leads any type vad, rep only	Leads (pneumatic/electrical) for use with any type electric/pneumatic ventricular assist device, replacement only
Q0488	Pwr pack base elec vad, rep	Power pack base for use with electric ventricular assist device, replacement only
Q0489	Pwr pck base combo vad, rep	Power pack base for use with electric/pneumatic ventricular assist device, replacement only
Q0490	Emr pwr source elec vad, rep	Emergency power source for use with electric ventricular assist device, replacement only
Q0491	Emr pwr source combo vad rep	Emergency power source for use with electric/pneumatic ventricular assist device, replacement only
Q0492	Emr pwr cbl elec vad, rep	Emergency power supply cable for use with electric ventricular assist device, replacement only
Q0493	Emr pwr cbl combo vad, rep	Emergency power supply cable for use with electric/pneumatic ventricular assist device, replacement only
Q0494	Emr hd pmp elec/combo, rep	Emergency hand pump for use with electric or electric/pneumatic ventricular assist device, replacement only
Q0495	Charger elec/combo vad, rep	Battery/power pack charger for use with electric or electric/pneumatic ventricular assist device, replacement only
Q0496	Battery elec/combo vad, rep	Battery, other than lithium-ion, for use with electric or electric/pneumatic ventricular assist device, replacement only
Q0497	Bat clps elec/comb vad, rep	Battery clips for use with electric or electric/pneumatic ventricular assist device, replacement only
Q0498	Holster elec/combo vad, rep	Holster for use with electric or electric/pneumatic ventricular assist device, replacement only
Q0499	Belt/vest elec/combo vad rep	Belt/vest/bag for use to carry external peripheral components of any type ventricular assist device, replacement only
Q0500	Filters elec/combo vad, rep	Filters for use with electric or electric/pneumatic ventricular assist device, replacement only
Q0501	Shwr cov elec/combo vad, rep	Shower cover for use with electric or electric/pneumatic ventricular assist device, replacement only
Q0502	Mobility cart pneum vad, rep	Mobility cart for pneumatic ventricular assist device, replacement only
Q0503	Battery pneum vad replacemnt	Battery for pneumatic ventricular assist device, replacement only, each
Q0504	Pwr adpt pneum vad, rep veh	Power adapter for pneumatic ventricular assist device, replacement only, vehicle type
Q0506	Lith-ion batt elec/pneum vad	Battery, lithium-ion, for use with electric or electric/pneumatic ventricular assist device, replacement only
Q0507	Misc sup/acc ext vad	Miscellaneous supply or accessory for use with an external ventricular assist device
Q0508	Mis sup/acc imp vad	Miscellaneous supply or accessory for use with an implanted ventricular assist device
Q0509	Mis sup/ac imp vad nopay med	Miscellaneous supply or accessory for use with any implanted ventricular assist device for which payment was not made under medicare part a
Q0510	Dispens fee immunosupressive	Pharmacy supply fee for initial immunosuppressive drug(s), first month following transplant
Q0511	Sup fee antiem,antica,immuno	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period
Q0512	Px sup fee anti-can sub pres	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period
Q0513	Disp fee inhal drugs/30 days	Pharmacy dispensing fee for inhalation drug(s); per 30 days
Q0514	Disp fee inhal drugs/90 days	Pharmacy dispensing fee for inhalation drug(s); per 90 days
Q0515	Sermorelin acetate injection	Injection, sermorelin acetate, 1 microgram
Q0516	Supply fee hiv prep 30-days	Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription drug, per 30-days
Q0517	Supply fee hiv prep 60-days	Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription drug, per 60-days
Q0518	Supply fee hiv prep 90-days	Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription drug, per 90-days